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TO THE EDITOR
Acne inversa (AI; also known as hidra-
denitis suppurativa; OMIM 142690) is a
chronic recurrent follicular occlusion
disorder. About 30–40% of patients with
AI exhibit a highly penetrant, autosomal
dominant mode of inheritance (Alikhan
et al., 2009). In many cases, AI patients
harbor heterozygous mutations in genes
encoding components of the g-secretase
complex, composed of presenilin (PS1
and 2), nicastrin (NCT), anterior pharynx
defective 1 (APH-1), and presenilin
enhancer 2 (PEN-2) (Wang et al.,
2010; Jurisch-Yaksi et al., 2013). PS is
the catalytic center of g-secretase that
promotes intramembranous proteolysis
of a number of membrane proteins,
including the amyloid precursor
protein (APP) and Notch 1–4, signaling
receptors essential for cell lineage
determination, cell proliferation and
survival. Activation of Notch signaling
occurs upon binding to the Delta/
Serrate/Lag-2 family of ligands on the
cell surface, leading to exposure of a
sequence near the transmembrane
domain that is a substrate of a metallo-
protease, ADAM 10. This ‘‘shedding’’
event generates the membrane-
tethered Notch extracellular truncation
(NEXT) that is then subject to intra-
membranous processing by g-secretase,
to generate the Notch intra-
cellular domain (NICD). NICD translo-
cates to the nucleus to form a complex
with a transcription factor, C-promoter
binding factor-1 (CBF-1), that binds
to CBF1-specific cognate DNA
sequences to regulate gene expression
(Fortini, 2009).
To date, 24 AI-specific mutations
have been identified in genes encoding
g-secretase components, and 19 of
these are in NCSTN, encoding nicastrin
(Supplementary Table S1 online). Most
mutations in NCSTN cause frameshift
and premature translation termination
as well as nonsense-mediated mRNA
decay, leading to significantly reduced
levels of NCT, findings which have led
to the proposal that AI is caused by
genetic haploinsufficiency because of
reduced g-secretase-mediated process-
ing of Notch and signaling in the skin
(Pink et al., 2013). Interestingly, four
missense mutations, V75I, D185N,
P211R, and Q216P, have been identi-
fied in the large ectodomain of NCT
(Li et al., 2011; Pink et al., 2012;
Zhang et al., 2013). These missense
mutations could potentially disrupt the
structure of this region and result in failed
assembly of the g-secretase complex,
leading to impaired activity. To test this
notion, we examined the activity of these
NCT variants in mediating Notch
processing and signaling.
We first coexpressed cDNAs encod-
ing the NCT missense variants together
with a constitutively activated mem-
brane-bound Notch 1 derivative (mNDE;
Schroeter et al., 1998) that is similar to
NEXT, in NCSTN-deficient (NCSTN / )
fibroblasts. mNDE is not subject to
intramembranous processing in the
absence of NCT (Figure 1a, lane 1),
but coexpression of wild-type NCT
rescues the generation of NICDAccepted article preview online 11 September 2014; published online 23 October 2014
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(Figure 1a, lane 2). Surprisingly, expres-
sion of the V75I, D185N, or P211R
variant also rescues g-secretase activity
efficiently (Figure 1a, lanes 3–5, respec-
tively), whereas the Q216P variant is
functionally inactive (Figure 1a, lane 6);
the identity of NICD was confirmed
with the Notch1744V-specific antibody,
D3B8 (Figure 1a). In addition, expression
of wild-type, V75I, D185N, or P211R
NCT variant rescues the endo-
proteolysis of PS1 that would otherwise
accumulate as a full-length molecule
in NCSTN / cells (Figure 1a), suggest-
ing that these variants assemble into
active g-secretase complexes (Zhang
et al., 2005). To confirm these results,
we have examined the processing of
full-length Notch 1 that is activated by
the addition of EDTA, leading to
exposure of an ADAM10 cleavage site
to generate NEXT (Rand et al.,
2000). Similar to the results obtained
using mNDE, expression of all but
the Q216P variant rescues Notch
processing (Figure 1b).
To further validate these results, we
employ a dual luciferase reporter assay
to examine NICD-mediated activation
of nuclear signaling. We coexpress
cDNAs encoding mNDE and NCT
variants together with cDNA encod-
ing firefly luciferase downstream of
four wild-type CBF1 binding sites
(4xWTCBF1Luc) (Shawber et al., 1996)
and cDNA encoding Renilla luciferase,
a transfection control, in NCSTN /
cells. Similar to wild-type NCT, expres-
sion of the V75I, D185N, or P211R
mutant leads to a significant trans-
activation of firefly luciferase (Figure 2),
whereas the Q216P variant fails to do
so. These results indicate that expression
of the V75I, D185N, and P211R
mutants can support Notch signaling
in vivo. Moreover, expression of the
V75I, D185N, or P211R mutant is also
functional in the generation of the APP
intracellular domain fragment derived
by g-secretase-mediated processing
of APP carboxyl-terminal fragments,
which accumulate in NCSTN / cells
(Supplementary Figure S1 online; com-
pare lane 1 with lanes 3–5). Finally,
coexpression of mNDE, wild-type
NCT, and each NCT mutant leads to
the production of NICD, findings
arguing against the possibility that the
mutant NCT variants act in a dominant-
negative manner (Supplementary
Figure S2 online).
The failure of Q216P to rescue Notch
processing and nuclear signaling sup-
ports the idea that impaired Notch
signaling underlies AI in these patients.
However, the V75I, D185N, and P211R
variants are active in promoting Notch
processing and signaling, and hence we
would argue that deficits in Notch sig-
naling are unlikely to be the cause of
disease in AI patients harboring these
mutations. These results strongly suggest
that V75I, D185N, and P211R variants
have a significant role in the pathogen-
esis of the disease but through mechan-
ism(s) other than impaired signaling by
Notch 1.
In summary, the preponderance of
evidence would support the notion that
mutations in genes encoding g-secretase
components cause AI because of
haploinsufficiency, and it has been pro-
posed that impaired Notch signaling is
central to the disease. Although plausi-
ble, we would argue that expression of
the remaining wild-type alleles encod-
ing g-secretase components in these
patients would be sufficient to promote
Notch signaling (Supplementary Figure
S2 online). On the other hand, it is
conceivable that g-secretase-mediated
proteolysis of any number of cell surface
receptors that also engage intracellular
signaling pathways is sensitive to the
levels or subcellular distribution of the
enzyme. Furthermore, local or extrinsic
factors involved in homeostasis in hair
follicles may have a significant effect on
disease pathogenesis (for review, see
Pink et al., 2013). Nevertheless, our
demonstration that a number of AI
disease–causing NCT missense variants
are fully active and capable of promot-
ing Notch signaling would argue against
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Figure 1. V75I, D185N, and P211R mutant nicastrin rescues Notch processing in NCSTN / cells.
(a) V75I, D185N, and P211R mutant nicastrin rescues membrane-bound Notch 1 derivative processing and
PS1 endoproteolysis in NCSTN /cells. (b) V75I, D185N, and P211R mutant nicastrin rescues full-length
Notch processing and PS1 endoproteolysis in NCSTN / cells. Notch intracellular domain fragments are
detected both by myc-tag and by Notch intracellular domain-specific antibody D3B8. *Indicates a
nonspecific band.
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the view that mutations in genes encod-
ing g-secretase components cause
disease simply as a result of haplo-
insufficiency that leads to impaired
Notch signaling.
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Gene Expression Differences between Psoriasis Patients
with and without Inflammatory Arthritis
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TO THE EDITOR
Genetic and cellular evidence implicate
both the innate and adaptive immune
systems in the pathogenesis of cuta-
neous psoriasis (PsC) and psoriatic
arthritis (PsA), an inflammatory arthritis
that develops in approximately 30% of
PsC patients (Gladman, 2005; O’Rielly
and Rahman, 2010; Lories and de Vlam,
2012). However, little is known about
the specific pathologic differences
between PsA and PsC. Comparison of
the gene expression profiles of PsC and
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Figure 2. V75I, D185N, and P211R mutant nicastrintransactivate C-promoter binding factor-1-luciferase
reporter construct in NCSTN / cells. Transient expression of wild-type and mutant NCT in NCSTN /
cells is performed to determine whether missense nicastrin variants can rescue Notch processing and
activate endogenous C-promoter binding factor-1 to transactivate luciferase reporter construct carrying four
copies of wild-type C-promoter binding factor-1 binding sites. Luciferase reporter construct carrying four
copies of mutant C-promoter binding factor-1 binding sites is used as a specificity control. The data
represent the mean±SEM (n¼ 3). ***Indicates a significant difference from the vector control (Po0.005).
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